ENDOCRINE DEPARTMENT – PUBLICATIONS (2016-2018)
Daskalakis K, Chatzelis E, Tsoli M, Papadopoulou-Marketou N, Dimitriadis GK, Tsolakis AV, Kaltsas G. Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms. Endocrine. 2018 Oct 2. doi: 10.1007/s12020-018-1773-3. [Epub ahead of print]
Giassa Τ, Mamali I, Gaki Ε, Kaltsas G, Kouraklis G, Markou ΚΒ, Karatzas T. Iodine intake and chronic autoimmune thyroiditis: a comparative study between coastal and mainland regions in Greece. Hormones (Athens). 2018 Sep 28. doi: 10.1007/s42000-018-0057-x. [Epub ahead of print]
Baudin E, Hayes A, Scoazec JY, Filosso PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudla B, Gorbounova V, Wiedenmann B, Nieveen van Dijkum E, Cwikla J, Falkerby J, Valle JW, Kulke MH, Caplin M. Unmet medical needs in pulmonary neuroendocrine (carcinoid) neoplasms. Neuroendocrinology. 2018 Sep 24. doi: 10.1159/000493980. [Epub ahead of print] PMID: 30248673
Daskalakis K, Kaltsas G, Öberg K, Tsolakis AV. Lung Carcinoids: long-term surgical results and the lack of prognostic value of somatostatin receptors and other novel IHC markers. Neuroendocrinology. 2018 Sep 23. doi: 10.1159/000493944. [Epub ahead of print] PMID: 30244255
Sorbye H, Baudin E, Borbath I, Caplin M, Chen J, Cwikla J, Frilling A, Grossman A, Kaltsas G, Scarpa A, Welin S, Garcia-Carbonero R. Unmet needs in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3). Neuroendocrinology. 2018 Aug 28. doi: 10.1159/000493318. [Epub ahead of print]
Dimitriadis GK, Adya R, Tan BK, Jones TA, Menon VS, Ramanjaneya M, Kaltsas G, Miras AD, Randeva HS. Effects of visfatin on brown adipose tissue energy regulation using T37i cells. Cytokine. 2018 Jul 27. pii: S1043-4666(18)30299-0. doi: 10.1016/j.cyto.2018.07.013. [Epub ahead of print] PMID: 30060995
Grozinsky-Glasberg S, Alexandraki KI, Angelousi A, Chatzellis E, Sougioultzis S, Kaltsas G. Gastric Carcinoids. Endocrinol Metab Clin North Am. 2018 Sep;47(3):645-660. doi: 10.1016/j.ecl.2018.04.013. Epub 2018 Jul 11. Review. PMID: 30098721
Anastasilakis AD, Tsoli M, Kaltsas G, Makras P. Bone metabolism in Langerhans cell histiocytosis. Endocr Connect. 2018 Jul;7(7):R246-R253. doi: 10.1530/EC-18-0186. Epub 2018 Jul 2. Review. PMID: 29967185
Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI. Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms. Ann Transl Med. 2018 Jun;6(12):252. doi: 10.21037/atm.2018.06.27. Review. PMID: 30069454
Kyritsi EM, Dimitriadis GK, Angelousi A, Mehta H, Shad A, Mytilinaiou M, Kaltsas G, Randeva HS. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome. Eur J Clin Invest. 2018 Jul;48(7):e12961. doi: 10.1111/eci.12961. Epub 2018 Jun 13.
Robbins HL, Symington M, Mosterman B, Goodby J, Davies L, Dimitriadis GK, Kaltsas G, Randeva HS, Weickert MO. Supplementation of Vitamin D Deficiency in Patients with Neuroendocrine Tumors Using Over-the-Counter Vitamin D3 Preparations. Nutr Cancer. 2018 Jul;70(5):748-754. doi: 10.1080/01635581.2018.1470650. Epub 2018 May 21. PMID: 29781720
Weickert MO, Kaltsas G, Hörsch D, Lapuerta P, Pavel M, Valle JW, Caplin ME, Bergsland E, Kunz PL, Anthony LB, Grande E, Öberg K, Welin S, Lombard-Bohas C, Ramage JK, Kittur A, Yang QM, Kulke MH. Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome. Clin Ther. 2018 Jun;40(6):952-962.e2. doi: 10.1016/j.clinthera.2018.04.006. Epub 2018 May 1. PMID: 29724499
Tsoukalas N, Baxevanos P, Aravantinou-Fatorou E, Tolia M, Galanopoulos M, Tsapakidis K, Kyrgias G, Toumpanakis C, Kaltsas G. Advances on systemic treatment for lung neuroendocrine neoplasms. Ann Transl Med. 2018 Apr;6(8):146. doi: 10.21037/atm.2018.04.03. Review. PMID: 29862235
Kanakis GA, Grimelius L, Papaioannou D, Kaltsas G, Tsolakis AV. Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids? Oncotarget. 2018 Apr 27;9(32):22653-22664. doi: 10.18632/oncotarget.25203. eCollection 2018 Apr 27. PMID: 29854305
Angelousi A, Kassi E, Nasiri-Ansari N, Weickert MO, Randeva H, Kaltsas G. Clock genes alterations and endocrine disorders. Eur J Clin Invest. 2018 Jun;48(6):e12927. doi: 10.1111/eci.12927. Epub 2018 Apr 16.
Dimitriadis GK, Kaur J, Adya R, Miras AD, Mattu HS, Hattersley JG, Kaltsas G, Tan BK, Randeva HS. Chemerin induces endothelial cell inflammation: activation of nuclear factor-kappa beta and monocyte-endothelial adhesion. Oncotarget. 2018 Mar 30;9(24):16678-16690. doi: 10.18632/oncotarget.24659. eCollection 2018 Mar 30. PMID: 29682177
Angelousi A, Cohen C, Sosa S, Danilowicz K, Papanastasiou L, Tsoli M, Pal A, Piaditis G, Grossman A, Kaltsas G. Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis. Horm Metab Res. 2018 Apr;50(4):296-302. doi: 10.1055/s-0044-101036. Epub 2018 Feb 19. PMID: 29458219
Grozinsky-Glasberg S, Kaltsas G, Kaltsatou M, Lev-Cohain N, Klimov A, Vergadis V, Uri I, Bloom AI, Gross DJ. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice. Endocrine. 2018 Jun;60(3):499-509. doi: 10.1007/s12020-018-1537-0. Epub 2018 Jan 30. PMID: 29383678
Angelousi A, Chatzellis E, Kaltsas G. New Molecular, Biological, and Immunological Agents Inducing Hypophysitis. Neuroendocrinology. 2018;106(1):89-100. doi: 10.1159/000480086. Epub 2017 Aug 8. PMID: 28797000
Pawa N, Clift AK, Osmani H, Drymousis P, Cichocki A, Flora R, Goldin R, Patsouras D, Baird A, Malczewska A, Kinross J, Faiz O, Antoniou A, Wasan H, Kaltsas GA, Darzi A, Cwikla JB, Frilling A. Surgical Management of Patients with Neuroendocrine Neoplasms of the Appendix: Appendectomy or More. Neuroendocrinology. 2018;106(3):242-251. doi: 10.1159/000478742. Epub 2017 Jun 23. PMID: 28641291
Alexandraki KI, Karapanagioti A, Karoumpalis I, Boutzios G, Kaltsas GA. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms. Biomed Res Int. 2017;2017:9856140. doi: 10.1155/2017/9856140. Epub 2017 Nov 19. Review. PMID: 29349087
Alexandraki K, Angelousi A, Boutzios G, Kyriakopoulos G, Rontogianni D, Kaltsas G. Management of neuroendocrine tumors of unknown primary. Rev Endocr Metab Disord. 2017 Dec;18(4):423-431. doi: 10.1007/s11154-017-9437-9. Review. PMID: 29199361
Angelousi A, Kaltsas G, Koumarianou A, Weickert MO, Grossman A. Chemotherapy in NETs: When and how. Rev Endocr Metab Disord. 2017 Dec;18(4):485-497. doi: 10.1007/s11154-017-9432-1. Review. PMID: 28890993
Tsoli M, Angelousi A, Rontogianni D, Stratakis C, Kaltsas G. Atypical manifestation of parathyroid carcinoma with late-onset distant metastases. Endocrinol Diabetes Metab Case Rep. 2017 Oct 28;2017. pii: 17-0106. doi: 10.1530/EDM-17-0106. eCollection 2017. PMID: 29118988
Alexandraki KI, Philippou A, Boutzios G, Theohari I, Koutsilieris M, Delladetsima IK, Kaltsas GA. IGF-IEc expression is increased in secondary compared to primary foci in neuroendocrine neoplasms. Oncotarget. 2017 Sep 8;8(45):79003-79011. doi: 10.18632/oncotarget.20743 eCollection 2017 Oct 3. PMID: 29108282
Xue M, Shafie A, Qaiser T, Rajpoot NM, Kaltsas G, James S, Gopalakrishnan K, Fisk A, Dimitriadis GK, Grammatopoulos DK, Rabbani N, Thornalley PJ, Weickert MO. Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET). Oncotarget. 2017 Aug 16;8(44):76961-76973. doi: 10.18632/oncotarget.20290. eCollection 2017 Sep 29. PMID: 29100361
Tsoukalas N, Chatzellis E, Rontogianni D, Alexandraki KI, Boutzios G, Angelousi A, Kaltsas G. Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature. Medicine (Baltimore). 2017 Apr;96(16):e6201. doi: 10.1097/MD.0000000000006201. Review. PMID: 28422824
Angelousi A, Dimitriadis GK, Zografos G, Nölting S, Kaltsas G, Grossman A. Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies. Endocr Relat Cancer. 2017 Jun;24(6):R239-R259. doi: 10.1530/ERC-16-0542. Epub 2017 Apr 11. Review. PMID: 28400402
Anastasilakis AD, Polyzos SA, Tsoli M, Papatheodorou A, Kokkoris P, Kaltsas G, Terpos E, Makras P. Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity. Metabolism. 2017 Jun;71:198-201. doi: 10.1016/j.metabol.2017.03.017. Epub 2017 Apr 4. PMID: 28521873
Dimitriadis GK, Angelousi A, Weickert MO, Randeva HS, Kaltsas G, Grossman A. Paraneoplastic endocrine syndromes. Endocr Relat Cancer. 2017 Jun;24(6):R173-R190. doi: 10.1530/ERC-17-0036. Epub 2017 Mar 24. Review. PMID: 28341725
Bonou M, Kapelios CJ, Kaltsas G, Perreas K, Toutouzas K, Barbetseas J. Cardiac Surgery for Carcinoid Heart Disease: A Weapon Not to Be Misused. Cardiology. 2017;136(4):243-251. doi: 10.1159/000450938. Epub 2016 Nov 11. Review. PMID: 27832643
Angelousi A, Kamp K, Kaltsatou M, O’Toole D, Kaltsas G, de Herder W. Sequential Everolimus and Sunitinib Treatment in Pancreatic Metastatic Well-Differentiated Neuroendocrine Tumours Resistant to Prior Treatments. Neuroendocrinology. 2017;105(4):394-402. doi: 10.1159/000456035. Epub 2017 Jan 26. PMID: 28122378
Papanastasiou L, Alexandraki KI, Androulakis II, Fountoulakis S, Kounadi T, Markou A, Tsiavos V, Samara C, Papaioannou TG, Piaditis G, Kaltsas G. Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up. Clin Endocrinol (Oxf). 2017 Apr;86(4):488-498. doi: 10.1111/cen.13294. Epub 2017 Jan 25. PMID: 27992961
Makras P, Tsoli M, Anastasilakis AD, Thanou M, Kaltsas G. Denosumab for the treatment of adult multisystem Langerhans cell histiocytosis. Metabolism. 2017 Apr;69:107-111. doi: 10.1016/j.metabol.2017.01.004. Epub 2017 Jan 12. PMID: 28285639
Kyritsi EM, Dimitriadis GK, Kyrou I, Kaltsas G, Randeva HS. PCOS remains a diagnosis of exclusion: a concise review of key endocrinopathies to exclude. Clin Endocrinol (Oxf). 2017 Jan;86(1):1-6. doi: 10.1111/cen.13245. Epub 2016 Oct 11. Review. PMID: 27664414
Pivonello C, Rousaki P, Negri M, Sarnataro M, Napolitano M, Marino FZ, Patalano R, De Martino MC, Sciammarella C, Faggiano A, Rocco G, Franco R, Kaltsas GA, Colao A, Pivonello R. Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study. Endocrine. 2017 Jun;56(3):603-620. doi: 10.1007/s12020-016-1079-2. Epub 2016 Sep 29.
Kaltsas G, Dimitriadis GK, Androulakis II, Grossman A. Paraneoplastic Syndromes related to Neuroendorine Tumours. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.2017 Feb 16